Various tumor types
Pilot ICK (Principal Investigator: prof. dr. H.M.W. Verheul / drs. M. Labots)
Pilot study on the determination of intratumoral concentrations of kinase inhibitors in patients with advanced solid malignancies.
MEDEA (Principal Investigator: Prof. dr. H.M.W. Verheul)
Metoclopramide, Dexamethasone or Aloxi for the prevention of delayed chemotherapy-induced nausea and vomiting in moderately emetogenic non-AC-based chemotherapy: the MEDEA trial.
OptiMal-trial (Principal Investigator: Prof. dr. H.M.W. Verheul)
Optimization of systemic treatment strategies in elderly patients with advanced solid Malignancies.
CPCT- 02 biopsy protocol (Principal Investigator: Prof. dr. H.M.W. Verheul)
Development of a platform for next-generation DNA sequencing based personalized treatment for cancer patients: Protocol to obtain biopsies from patients with locally advanced (incurable) or metastatic cancer.
SIGN protocol (Principal Investigator: Prof. dr. H.M.W. Verheul/ Prof. dr. J. Dekker)
Supporting Resilience and Case Finding. Evaluation of an Innovative Procedure for Detecting Psychological Distress in Patients with Cancer
ROAR (BRF117019) (Principal Investigator: dr. M. van Linde)
A Phase II, Open-label, Study in Subjects with BRAF V600EMutated Rare Cancers with Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib.
The DRUP trial (Principal Investigator: prof. dr. H.M.W. Verheul)
A National Study to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile.
Counting steps (Principal Investigator: prof. dr. H.M.W. Verheul)
Counting steps in cancer patients.